SPE2D219D0075P00005 signed.pdf
PDF 1 MB Posted
- Attached to
- Budesonide Inhalation Suspension Federal contract opportunity
- Solicitation number
- SPE2D2-18-R-0025
About this file
This document outlines a federal contract opportunity for Budesonide Inhalation Suspension. The Defense Logistics Agency plans to issue a solicitation for a national requirements contract to supply Budesonide Inhalation Suspension in 1MG/2ML, 0.25MG/2ML, and 0.5MG/2ML packaging containing 30 ampules per carton. The contract will be a firm-fixed price, requirements-type contract with a one-year base period and four one-year options. It will establish a national supply source in accordance with FAR 52.216-21 to provide the items for purchase by the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs through DLA and VA prime vendor programs. Interested parties should contact the specified individual for any questions and are advised to set up automatic notifications for pre-solicitation or solicitation changes through the identified website.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| SF30_SPE2D219D0075P00007 released.pdf | ||
| SF30_SPE2D219D0075P00006 released.PDF | ||
| SPE2D219D0075P00003 signed.pdf | ||
| SPE2D219D0075P00006 signed.pdf | ||
| SPE2D219D0075P00004 signed.pdf | ||
| SPE2D219D0075P00002.pdf | ||
| SPE2D219D0075_P00001.PDF | ||
| Budesonide_Award_SPE2D219D0075_OFFICIAL_SIGNED.pdf | ||
| SPE2D218R00250003_AMENDMENT.pdf | ||
| SPE2D218R00250003_SOLICITATION.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED:
PAGE 2 OF 2 PAGES
SPE2D2-19-D-0075 / P00005
1. Option 2 is hereby exercised for the period of July 1, 2021 through June 30, 2022.
2. The price changed for the following NDC:
76282-0641-38 Budesonide Inhalation Suspension 0.5MG/2ML (30 count) lowered from $38.00 to $28.92
3. All other terms and conditions remain the same.
| 2021-06-29T08:54:52-0400 | |
| WRAY.JASON.CHRISTOPHER.1238740742 |
| Text2: Jason Wray |
| Text3: 6/29/2021 |
File details come from the government source that posted it. Updated .